Identification of Bladder Cancer Patients at Risk for Recurrence or Progression: An Immunohistochemical Study Based on the Expression of Metallothionein

By Hinkel Andreas   Schmidtchen Sonja   Palisaar Rein-Jueri   Noldus Joachim   Pannek Jurgen  

Journal of Toxicology and Environmental Health, Vol. 71, Iss. 13-14, 2008-01 ,pp. : 954-959

Taylor & Francis Ltd

Access to resources Recommend Favorite

Characterization of bradykinin B 2 receptor antagonists in human and rat urinary bladder

By Meini S.   Patacchini R.   Giuliani S.   Lazzeri M.   Turini D.   Maggi C.A.   Lecci A.  

European Journal of Pharmacology, Vol. 388, Iss. 2, 2000-01 ,pp. : 177-182

Elsevier

Access to resources Recommend Favorite

The role of peroxisome proliferator-activated receptor in bladder cancer in relation to angiogenesis and progression

By Possati L.   Rocchetti R.   Talevi S.   Beatrici V.   Margiotta C.   Ferrante L.   Calza R.   Sagrini D.   Ferri A.  

General Pharmacology, Vol. 35, Iss. 5, 2000-11 ,pp. : 269-275

Elsevier

Access to resources Recommend Favorite

Animal models of urinary bladder cancer and their application to novel drug discovery

By Oliveira Paula A   Arantes-Rodrigues Regina   Vasconcelos-Nóbrega Carmen  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 5, 2014-05 ,pp. : 485-503

Informa Healthcare

Access to resources Recommend Favorite

Increased Urinary Tissue Factor Levels in Patients with Advanced Bladder Cancer

By Lwaleed B.A.  

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 103-104

Ashgate Publishing Ltd

Access to resources Recommend Favorite